Business Model

Home // Formulation Development // Business Model

Enaltec has evolved in its business strategies with the supply of its API business to the semi-regulated market (Southeast Asia, Latin America, Russia etc.) and subsequently graduating to the supply of APIs to the regulated markets (USA, EU, JAPAN, CANADA, and AUSTRALIA).

Enaltec now also offers clients its expertise in formulation development and works with clients across the globe in the areas of contract research and development under various business models.

Enaltec provides a complete seamless package for a client, right from the API development and sourcing to the final dossier submission, in the respective regulated markets.

  • Client agrees to a project cost under the agreed scope of work and the project cost is split into milestones which gets paid on achievement of the deliverables attached to the milestones

    The project is deemed complete after successful technology transfer of the product to the clients manufacturing site and/or successful Bio Equivalence

    Client compiles and files the dossier to the regulatory agencies

  • Financial Contribution to the Project by Enaltec

    Profits split after launch of Product in the ratio of Investment

    Backward integrated projects with API of interest in this model

    The services which Enaltec provides under turnkey are the following:

    • Enaltec is integrated backwards with its API development and manufacturing facility; hence can provide their own API or can support clients in procurement of API from other suppliers

    • Enaltec has an in-house IPM team which takes care of the patent evaluation with respect to API / formulation

    • The formulation R & D of Enaltec takes care of development of complex generic formulations, its analytical method development and validation.

    • Enaltec takes the responsibility of technology transfer of the formulation from its R & D facility to the preferred manufacturing partner or the client manufacturing site

    Enaltec’ s Clinical monitoring team identifies and selects the sites for BA / BE studies and monitors the studies completely

    Enaltec’s regulatory team takes care of the complete dossier compilation and submission in their respective authorities.

    Enaltec’ s main strength is its team that is globally experienced and highly qualified. Hence Enaltec is able to provide advanced research and development capabilities and processes that create quality speciality and generic products.

  • Enaltec is actively looking for licensing partners to market their finished pharmaceutical products across the globe. Our offerings include 4 ANDA approved products as well as 75+ FDF products for tech transfer which can be tailored as per market requirement. We are open to discuss licensing or acquisition from our proprietary and partner developments.